Abstract
Stroke increases the risk of hip fracture on the affected side. Although bone is lost by 1 year, rapidity of onset and relationship with immobility are uncertain. Using the bone resorption marker urinary cross-linked N telopeptide of type I collagen (uNTx), we examined bone resorption in the first 4 weeks after stroke, relating uNTx with bone density and mobility in subjects over 60 years. Two separate control groups acted as comparators, healthy (HC) and institutionalized (IC) controls, the latter to control for the effects of institutionalization. uNTx, urinary calcium (both related to creatinine and log-transformed), heel bone mineral density (BMD), Tinetti scores, and Barthel scores for prestroke function were measured. Log uNTx/Cr was lower in males compared with females, but this difference was not evident in stroke or IC subjects. Log uNTx/Cr was inversely related with BMD in females from both control groups and in male stroke subjects. Tinetti scores were divided into tertiles and were lower in stroke than IC subjects (P < 0.01). Log uNTx/Cr was similar in stroke and IC subjects in the lowest Tinetti tertile. Log uNTx/Cr was higher in stroke subjects of both sexes in the lowest tertile compared with the higher two tertiles combined (P < 0.05) and higher in all tertiles compared with HC subjects (P < 0.05). Subjects with a prestroke Barthel index of ≤17 had higher log uNTx/Cr compared with HCs. Log uCa/Cr was higher only in male stroke patients. Bone resorption in stroke starts early, and measures to reduce this are merited.
Similar content being viewed by others
References
Davie MWJ, Hill SN, Haddaway MJ (2003) Consequences of stroke on the skeleton. Rev Clin Gerontol 13:11–23
Beaupre GS, Lew HL (2006) Bone-density changes after stroke. Am J Phys Med Rehabil 85:464–472
Myint PK, Poole KE, Warburton EA (2007) Hip fractures after stroke and their prevention. QJM 100:539–545
Hamdy RC, Krishnaswamy G, Cancellaro V, Whalen K, Harvill L (1993) Changes in bone mineral content and density after stroke. Am J Phys Med Rehabil 72:188–191
del Puente A, Pappone N, Mandes MG, Mantova D, Scarpa R, Oriente P (1996) Determinants of bone mineral density in immobilization: a study on hemiplegic patients. Osteoporos Int 6:50–54
Takamoto S, Masuyama T, Nakajima M, Seikiya K, Kosaka H, Morimoto S, Ogihara T, Onishi T (1995) Alterations of bone mineral density of the femurs in hemiplegia. Calcif Tissue Int 56:259–262
Browner WS, Pressman AR, Nevitt MC, Cauley JA, Cummings SR (1993) Association between low bone density and stroke in elderly women. The study of osteoporotic fractures. Stroke 24:940–946
Jorgensen L, Engstad T, Jacobsen BK (2001) Bone mineral density in acute stroke patients: low bone mineral density may predict first stroke in women. Stroke 32:47–51
Chiu KY, Pun WK, Luk KD, Chow SP (1992) A prospective study on hip fractures in patients with previous cerebrovascular accidents. Injury 23:297–299
Dennis MS, Lo KM, McDowall M, West T (2002) Fractures after stroke: frequency, types, and associations. Stroke 33:728–734
Chiu KY, Pun WK, Luk KD, Chow SP (1992) Sequential fractures of both hips in elderly patients—a prospective study. J Trauma 32:584–587
Ramnemark A, Nilsson M, Borssen B, Gustafson Y (2000) Stroke, a major and increasing risk factor for femoral neck fracture. Stroke 31:1572–1577
Sato Y, Iwamoto J, Kanoko T, Satoh K (2005) Risedronate therapy for prevention of hip fracture after stroke in elderly women. Neurology 64:811–816
Sato Y, Iwamoto J, Kanoko T, Satoh K (2005) Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. Arch Intern Med 165:1743–1748
Poole KE, Loveridge N, Rose CM, Warburton EA, Reeve J (2007) A single infusion of zoledronate prevents bone loss after stroke. Stroke 38:1519–1525
Poole KE, Warburton EA, Reeve J (2005) Risedronate therapy for prevention of hip fracture after stroke in elderly women. Neurology 65:1513–1514
Leeming DJ, Koizumi M, Byearsjalsen I, Li B, Qvist P, Tanko LB (2006) The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients. Cancer Epidemiol Biomarkers Prev 15:32–38
Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD (1994) Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 79:1693–1700
Sharp CA, Evans SF, Risteli L, Risteli J, Worsfold M, Davie MW (1996) Effects of low- and conventional-dose transcutaneous HRT over 2 years on bone metabolism in younger and older postmenopausal women. Eur J Clin Invest 26:763–771
Sato Y, Fujimatsu Y, Kikuyama M, Kaji M, Oizumie K (1998) Influence of immobilisation on bone mass and bone metabolism in hemiplegic elderly patients with a long-standing stroke. J Neurol Sci 156:205–210
Sato Y, Kuno H, Kaji M, Etoh K, Oizumi K (2000) Influence of immobilization upon calcium metabolism in the week following hemiplegic stroke. J Neurol Sci 175:135–139
Sharp CA, Inman C, Worsfold M, Risteli J, Davie MWJ (1995) Bone turnover after spinal cord injury. Bone 16:186S
Davie MW, Sharp CA, Haddaway MJ (1999) Different mechanisms of bone metabolism between patients with stroke and with spinal cord injury. J Neurol Sci 163:99–101
Worsfold M, Powell DE, Jones TJ, Davie MW (2004) Assessment of urinary bone markers for monitoring treatment of osteoporosis. Clin Chem 50:2263–2270
Donescu OS, Battie MC, Videman T, Risteli J, Eyearse D (2006) The predictive role of bone turnover markers for BMD in middle-aged men. Aging Male 9:97–102
Dresner-Pollak R, Parker RA, Poku M, Thompson J, Seibel MJ, Greenspan SL (1996) Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcif Tissue Int 59:328–333
Dresner-Pollak R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW (2000) Bone mineral metabolism in adults with beta-thalassaemia major and intermedia. Br J Haematol 111:902–907
Krall EA, Dawson-Hughes B, Hirst K, Gallagher JC, Sherman SS, Dalsky G (1997) Bone mineral density and biochemical markers of bone turnover in healthy elderly men and women. J Gerontol A Biol Sci Med Sci 52:M61–M67
Bainbridge NJ, Davie MW, Haddaway MJ (2006) Bone loss after stroke over 52 weeks at os calcis: influence of sex, mobility and relation to bone density at other sites. Age Ageing 35:127–132
Levendoglu F, Ugurlu H, Gurbilek M, Akkurt E, Karagozolu E (2004) Increased bone resorption in the proximal femur in patients with hemiplegia. Am J Phys Med Rehabil 83:835–841
Theiler R, Stahelin HB, Kranzlin M, Tyndall A, Bischoff HA (1999) High bone turnover in the elderly. Arch Phys Med Rehabil 80:485–489
Van Ouwenaller C, Uebelhart D, Chantraine A (1989) Bone metabolism in hemiplegic patients. Scand J Rehabil Med 21:165–170
Tinetti ME (1986) Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc 34:119–126
Moorehead WR, Biggs HG (1974) 2-Amino–2-methyl-1-propanol as the alkalizing agent in an improved continuous-flow cresolphthalein complexone procedure for calcium in serum. Clin Chem 20:1458–1460
Sone T, Miyake M, Takeda N, Fukunaga M (1995) Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: age- and sex-related changes and reference limits. Bone 17:335–339
Kenny AM, Gallagher JC, Prestwood KM, Gruman CA, Raisz LG (1998) Bone density, bone turnover, and hormone levels in men over age 75. J Gerontol A Biol Sci Med Sci 53:M419–M425
Orwoll ES, Bell NH, Nanes MS, Flessland KA, Pettinger MB, Mallinak NJ, Cain DF (1998) Collagen N-telopeptide excretion in men: the effects of age and intrasubject variability. J Clin Endocrinol Metab 83:3930–3935
Gallagher JC, Kinyamu HK, Fowler SE, Dawson-Hughes B, Dalsky GP, Sherman SS (1998) Calciotropic hormones and bone markers in the elderly. J Bone Miner Res 13:475–482
Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB (1998) Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial. J Bone Miner Res 13:1431–1438
Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY Study. J Bone Miner Res 15:1526–1536
LeBlanc AD, Spector ER, Evans HJ, Sibonga JD (2007) Skeletal responses to spaceflight and the bed rest analog: a review. J Musculoskelet Neuronal Interact 7:33–47
Chow YW, Inman C, Pollintine P, Sharp CA, Haddaway MJ, el Masry W, Davie MW (1996) Ultrasound bone densitometry and dual energy X-ray absorptiometry in patients with spinal cord injury: a cross-sectional study. Spinal Cord 34:736–741
Smith SM, Nillen JL, Leblanc A, Lipton A, Demers LM, Lane HW, Leach CS (1998) Collagen cross-link excretion during spaceflight and bed rest. J Clin Endocrinol Metab 83:3584–3591
Baecker N, Tomic A, Mika C, Gotzmann A, Platen P, Gerzer R, Heer M (2003) Bone resorption is induced on the second day of bed rest: results of a controlled crossover trial. J Appl Physiol 95:977–982
Davie MW, Abraham RR, Hewins B, Wynn V (1986) Changes in bone and muscle constituents during dieting for obesity. Clin Sci (Lond) 70:285–293
Ricci TA, Heymsfield SB, Pierson RN Jr, Stahl T, Chowdhury HA, Shapses SA (2001) Moderate energy restriction increases bone resorption in obese postmenopausal women. Am J Clin Nutr 73:347–352
Villareal DT, Miller BV III, Banks M, Fontana L, Sinacore DR, Klein S (2006) Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults. Am J Clin Nutr 84:1317–1323
Compston JE, Laskey MA, Croucher PI, Coxon A, Kreitzman S (1992) Effect of diet-induced weight loss on total body bone mass. Clin Sci (Lond) 82:429–432
Poole KE, Loveridge N, Barker PJ, Halsall DJ, Rose C, Reeve J, Warburton EA (2006) Reduced vitamin D in acute stroke. Stroke 37:243–245
Melton LJIII, Khosla S, Atkinson EJ, O’Fallon WM, Riggs BL (1997) Relationship of bone turnover to bone density and fractures. J Bone Miner Res 12:1083–1091
Haddaway M, Davie MW, Steele R, Hill S (1999) Ultrasound densitometry of the os calcis in patients with hemiparesis following a cerebrovascular accident. Calcif Tissue Int 65:436–441
Qvist P, Christgau S, Pedersen BJ, Schlemmer A, Christiansen C (2002) Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone 31:57–61
Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348:1535–1541
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Haddaway, M.J., Bainbridge, N.J., Powell, D.E. et al. Bone Resorption in Stroke and Institutionalized Subjects. Calcif Tissue Int 84, 118–125 (2009). https://doi.org/10.1007/s00223-008-9203-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-008-9203-9